Brief: Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne

Epirus Biopharmaceuticals

14/06/2016 21:08

June 14 (Reuters) - Epirus Biopharmaceuticals: 
    * On June 13, 2016,  entered into a binding term sheet with 
Zaklady Farmaceutyczne 'Polpharma' S.A. 
    * Will sell to Polpharma all outstanding shares of Epirus 
Biopharmaceuticals (Netherlands) in exchange for payment of $3.5 
million in cash 
    * Says Polpharma will acquire ownership of Epirus 
Netherlands' proprietary CHOBC cell line platform 
    * Says Epirus will retain exclusive rights to develop BOW080 
and BOW070 
    * Will continue to pursue restructuring efforts, including 
possible creation of separate co focused on rare disease 
biological product opportunities 
 
Source text - http://1.usa.gov/1tpfYX7 
 
 ((Bengaluru Newsroom: +1-646-223-8780))